<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116131">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02089568</url>
  </required_header>
  <id_info>
    <org_study_id>POWAR</org_study_id>
    <secondary_id>2012-000942-36</secondary_id>
    <nct_id>NCT02089568</nct_id>
  </id_info>
  <brief_title>Prophylaxis Of Wound Infections- Antibiotics in Renal Donation</brief_title>
  <acronym>POWAR</acronym>
  <official_title>Are Prophylactic Antibiotics Necessary Before Laparoscopic Living Kidney Donation? A Double Blind, Randomised, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to see whether antibiotics given at the start of laparoscopic
      kidney donation surgery prevent infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects undergoing laparoscopic donor nephrectomy will be randomised to either a single
      dose of intravenous co-amoxiclav or placebo prior to surgery. Outcome measures include any
      infections, length of stay and costs
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rate of infection after surgery</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultrasonic evidence of wound healing</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Wounds will be assessed using high resolution ultrasound to assess dermal and epidermal healing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rates</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic associated side effects</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Including diarrhoea and allergic reactions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work and normal activities</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative costs</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Drug: co-amoxiclav</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>experimental</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Co-Amoxiclav</intervention_name>
    <description>Will receive 1.2g co-amoxiclav at induction</description>
    <arm_group_label>Drug: co-amoxiclav</arm_group_label>
    <other_name>Augmentin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Placebo - 0.9% saline</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients (over 18 years) undergoing hand-assisted laparoscopic donor
             nephrectomy, who have given written informed consent, will be included.

          -  Patients whose first language is not English will be included; they comprise a
             significant part of our patient population and we will use translation services as is
             our normal practice.

          -  Women of child-bearing age taking adequate contraception will be included.

        Exclusion Criteria:

          -  Patients with a known allergy to penicillin or other antibiotics.

          -  Patients with MRSA colonisation.

          -  Participation in another investigational study within the previous 90 days.

          -  Pregnant or breast-feeding women.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nizam Mamode</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nizam Mamode</last_name>
    <email>nizam.mamode@gstt.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nizam Mamode</last_name>
      <email>nizam.mamode@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jonathon Olsburgh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicos Kessaris</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guy's and St Thomas' NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Nizam Mamode</investigator_full_name>
    <investigator_title>Consultant Transplant Surgeon</investigator_title>
  </responsible_party>
  <keyword>Living donation</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
